Global Alfentanil Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Alfentanil Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Alfentanil is a potent but short-acting synthetic opioid analgesic drug, used for anaesthesia in surgery. It is an analogue of fentanyl with around 1/4 to 1/10 the potency of fentanyl and around 1/3 of the duration of action, but with an onset of effects 4x faster than fentanyl. Alfentanil has a pKa of approximately 6.5, which leads to a very high proportion of the drug being uncharged at physiologic pH. This unique characteristic is responsible for its rapid onset. It is an agonist at mu opioid receptors
Alfentanil report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Alfentanil market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Perioperative Analgesia and Adjunct to General Anesthesia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Alfentanil industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Alfentanil key manufacturers include Akorn, Pfizer, Hameln Pharmaceuticals, JV Healthcare, Novartis, Angelini Pharma, Johnson & Johnson, CristÁLia and Auden Mckenzie, etc. Akorn, Pfizer, Hameln Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Alfentanil can be divided into Intravenous and Subcutaneous, etc. Intravenous is the mainstream product in the market, accounting for % sales share globally in 2022.
Alfentanil is widely used in various fields, such as Perioperative Analgesia and Adjunct to General Anesthesia, etc. Perioperative Analgesia provides greatest supports to the Alfentanil industry development. In 2022, global % sales of Alfentanil went into Perioperative Analgesia filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alfentanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Akorn
Pfizer
Hameln Pharmaceuticals
JV Healthcare
Novartis
Angelini Pharma
Johnson & Johnson
CristÁLia
Auden Mckenzie
Horizon Hospital Healthcare
Algol Pharma
Max Health
Segment by Type
Intravenous
Subcutaneous
Perioperative Analgesia
Adjunct to General Anesthesia
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alfentanil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Alfentanil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Alfentanil industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Alfentanil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Alfentanil introduction, etc. Alfentanil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Alfentanil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Alfentanil report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Alfentanil market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Perioperative Analgesia and Adjunct to General Anesthesia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Alfentanil industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Alfentanil key manufacturers include Akorn, Pfizer, Hameln Pharmaceuticals, JV Healthcare, Novartis, Angelini Pharma, Johnson & Johnson, CristÁLia and Auden Mckenzie, etc. Akorn, Pfizer, Hameln Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Alfentanil can be divided into Intravenous and Subcutaneous, etc. Intravenous is the mainstream product in the market, accounting for % sales share globally in 2022.
Alfentanil is widely used in various fields, such as Perioperative Analgesia and Adjunct to General Anesthesia, etc. Perioperative Analgesia provides greatest supports to the Alfentanil industry development. In 2022, global % sales of Alfentanil went into Perioperative Analgesia filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alfentanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Akorn
Pfizer
Hameln Pharmaceuticals
JV Healthcare
Novartis
Angelini Pharma
Johnson & Johnson
CristÁLia
Auden Mckenzie
Horizon Hospital Healthcare
Algol Pharma
Max Health
Segment by Type
Intravenous
Subcutaneous
Segment by Application
Perioperative Analgesia
Adjunct to General Anesthesia
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alfentanil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Alfentanil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Alfentanil industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Alfentanil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Alfentanil introduction, etc. Alfentanil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Alfentanil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices